Relief Therapeutics Holding AG (RLFTF)

[IBRICH619]

GAME CHANGER..

RLF-100 is currently being used only on patients already on a ventilator.

But the FDA has now approved expanding the study to patients in respiratory distress before a ventilator is needed.

Dr. Jonathan Javitt, the CEO of NeuroRx, said, “They will take it with a nebulizer. That’s a machine that lets you take a drug and turn it into cold steam and you inhale it. People with asthma know about nebulizers.”

U.M. doctors said this is a blind test, so some patients will get the drug and others will get a placebo.

Jayaweera said, “We will say we don’t know, we don’t know whether this drug will work or not. We’re going to test it, and whatever the results are, that’s what we get.”

If the results are good, the drugs could be expanded to hospitals nationwide and could be used at home to prevent hospitalization.